These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 26637782

  • 1. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
    Coppo P, Froissart A, French Reference Center for Thrombotic Microangiopathies.
    Hematology Am Soc Hematol Educ Program; 2015; 2015():637-43. PubMed ID: 26637782
    [Abstract] [Full Text] [Related]

  • 2. Management of thrombotic thrombocytopenic purpura.
    Coppo P, French Reference Center for Thrombotic Microangiopathies.
    Transfus Clin Biol; 2017 Sep; 24(3):148-153. PubMed ID: 28645643
    [Abstract] [Full Text] [Related]

  • 3. Treatment of autoimmune thrombotic thrombocytopenic purpura in the more severe forms.
    Coppo P, French Reference Center for Thrombotic Microangiopathies.
    Transfus Apher Sci; 2017 Feb; 56(1):52-56. PubMed ID: 28110841
    [Abstract] [Full Text] [Related]

  • 4. Thrombotic thrombocytopenic purpura.
    Joly BS, Coppo P, Veyradier A.
    Blood; 2017 May 25; 129(21):2836-2846. PubMed ID: 28416507
    [Abstract] [Full Text] [Related]

  • 5. Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura.
    Dane K, Chaturvedi S.
    Hematology Am Soc Hematol Educ Program; 2018 Nov 30; 2018(1):539-547. PubMed ID: 30504355
    [Abstract] [Full Text] [Related]

  • 6. Inherited and acquired thrombotic thrombocytopenic purpura (TTP) in adults.
    Knöbl P.
    Semin Thromb Hemost; 2014 Jun 30; 40(4):493-502. PubMed ID: 24802084
    [Abstract] [Full Text] [Related]

  • 7. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
    Coppo P, Veyradier A.
    Presse Med; 2012 Mar 30; 41(3 Pt 2):e163-76. PubMed ID: 22265954
    [Abstract] [Full Text] [Related]

  • 8. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
    Pandey S, Nakagawa M, Rosenbaum ER, Arnaoutakis K, Hutchins LF, Makhoul I, Milojkovic N, Cottler-Fox M.
    J Clin Apher; 2015 Feb 30; 30(1):50-4. PubMed ID: 25042026
    [Abstract] [Full Text] [Related]

  • 9. Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.
    Patriquin CJ, Thomas MR, Dutt T, McGuckin S, Blombery PA, Cranfield T, Westwood JP, Scully M.
    Br J Haematol; 2016 Jun 30; 173(5):779-85. PubMed ID: 27009919
    [Abstract] [Full Text] [Related]

  • 10. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M, Benhamou Y, Delmas Y, Pichereau C, Maury E, Pène F, Halimi JM, Presne C, Thouret JM, Veyradier A, Coppo P.
    Eur J Haematol; 2016 Aug 30; 97(2):183-91. PubMed ID: 26608617
    [Abstract] [Full Text] [Related]

  • 11. Current management of thrombotic thrombocytopenic purpura.
    Kremer Hovinga JA, Meyer SC.
    Curr Opin Hematol; 2008 Sep 30; 15(5):445-50. PubMed ID: 18695366
    [Abstract] [Full Text] [Related]

  • 12. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Sadler JE.
    Blood; 2008 Jul 01; 112(1):11-8. PubMed ID: 18574040
    [Abstract] [Full Text] [Related]

  • 13. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL, Price TH, Howell C, Delaney M.
    J Clin Apher; 2013 Dec 01; 28(6):416-21. PubMed ID: 23857424
    [Abstract] [Full Text] [Related]

  • 14. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura.
    George JN.
    Am J Hematol; 2012 May 01; 87 Suppl 1():S88-91. PubMed ID: 22407740
    [Abstract] [Full Text] [Related]

  • 15. Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report.
    Yates S, Matevosyan K, Rutherford C, Shen YM, Sarode R.
    Transfusion; 2014 Aug 01; 54(8):2064-7. PubMed ID: 24655327
    [Abstract] [Full Text] [Related]

  • 16. Thrombotic thrombocytopenic purpura-what is new?
    Shah N, Sarode R.
    J Clin Apher; 2013 Feb 01; 28(1):30-5. PubMed ID: 23420593
    [Abstract] [Full Text] [Related]

  • 17. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M, Betz C, Miesbach W, Krause M, von Auer C, Geiger H, Scharrer I.
    Br J Haematol; 2005 Jun 01; 129(5):644-52. PubMed ID: 15916687
    [Abstract] [Full Text] [Related]

  • 18. Treatment of refractory thrombotic thrombocytopenic purpura using multimodality therapy including splenectomy and cyclosporine.
    Jhaveri KD, Scheuer A, Cohen J, Gordon B.
    Transfus Apher Sci; 2009 Aug 01; 41(1):19-22. PubMed ID: 19520610
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.